LEUVEN, Belgium, November 6 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update for the nine months period ended 30 September 2008.

LONDON and NEW YORK, November 6 /PRNewswire/ --

Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, today announced positive data from its ICH compliant Phase II equivalent multi-center study of MRX-4 (n=105) in patients suffering from allergic rhinitis. MRX-4 was given as an intranasal spray formulation.

WALTHAM, Massachusetts, November 6 /PRNewswire/ --

What: Yiannis Pavlosoglou, senior director in EMEA for Ounce Labs, industry leader in static application security ( http://www.ouncelabs.com/resources/application-vulnerabilities-faq.asp ) testing (SAST), will present a session titled 'Hybrid Code Auditing: A Dataflow Source Code Review Methodology' at DeepSec 2008 this week in Vienna, Austria.

Session Overview:

TORONTO, November 6 /PRNewswire/ -- Patheon (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, today announced the opening of its new headquarters for its European operations in Zug, Switzerland, near Zurich. The new headquarters will manage the Company's commercial and pharmaceutical development services sales, marketing and customer support activities in Europe. Certain support functions will be managed in Zug as well, such as procurement and supply chain.

HONG KONG, November 6 /PRNewswire/ --

- From 64 countries around the world, 250 teachers, school administrators and education policymakers meet to reward educator excellence.

Today in Hong Kong, teachers were recognized for their creativity and innovation in the classroom as part of Microsoft Corp.'s 2008 Worldwide Innovative Teachers Forum (ITF). Now in its fourth year, the Worldwide ITF rewards outstanding teachers who practice exceptional 21st century learning and incorporate the creative use of technology in their classrooms.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO )

TURKU, Finland, November 6 /PRNewswire/ -- BioCis Pharma Ltd a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. The double-blind, vehicle-controlled study is designed to evaluate the tolerability and efficacy of the topical product in a total of 18 subjects with mild to moderate forms of atopic dermatitis. The subjects will apply ProtoCure(TM) emulsion cream up to four weeks to the skin areas affected by the disease.

NOVATO, California, November 6 /PRNewswire/ --

- Enters Collaboration on Receptor Associated Protein (RAP)

- Supports NeuroTrans(TM) Platform with Japanese Patent

Raptor Pharmaceuticals Corp. (Raptor or the Company) (OTC Bulletin Board: RPTP), today announced updates on its preclinical program which utilizes drug-targeting platforms derived from the human receptor-associated protein (RAP) and related proteins. The Company signed a collaborative research agreement with the Brigham and Women's Hospital involving the characterization of certain modified RAP proteins. At the Hospital, this research will be conducted in the laboratory of Dr. Stephen Blacklow. The Company has also announced today a patent issuance in Japan relating to the NeuroTrans(TM) program.

HELSINKI, November 6 /PRNewswire/ --

- Orascom Telecom Subsidiary Will use Comptel Solution to Improve Fulfillment Processes for Mobile Services

Comptel Corporation (OMX Helsinki: CTL1V), the leading vendor of dynamic Operations Support System (OSS) software, announced today that Algerian mobile operator Orascom Telecom Algerie OTA (Djezzy), a fully owned subsidiary of Orascom Telecom Holding, has selected Comptel Provisioning and Activation Solution. This deal follows the announcements in 2007 of Comptel being chosen as preferred supplier by Orascom Telecom, and of the subsequent selection by Orascom joint venture Tunisiana.